Kinga Winczura

Kinga Winczura

Auto-generated profile, based on publicly available information

Kinga Winczura

Division of Molecular and Cellular Function, School of Biological Sciences, University of Manchester, Oxford Road, Manchester, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2021 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
LMLazaros Melidis
Lazaros Melidis
HHHarriet James Hill
Harriet James Hill
NCNicholas J. Coltman
Nicholas J. Coltman
SDScott P. Davies
Scott P. Davies
KWKinga Winczura
Kinga Winczura
MHMichael J. Hannon
Michael J. Hannon
The untranslated regions (UTRs) of viral genomes contain a variety of conserved yet dynamic structures crucial for viral replication, providing drug targets for the development of broad spectrum anti‐virals. We combine in vitro RNA analysis with molecular dynamics simulations to build the first 3D models of the structure and dynamics of key regions of the 5′ UTR of the SARS‐CoV‐2 genome. Furthermore, we determine the binding of metallo‐supramolecular helicates (cylinders) to this RNA structure. These nano‐size agents are uniquely able to thread through RNA junctions and we identify their binding to a 3‐base bulge and the central cross 4‐way junction located in stem loop 5. Finally, we show these RNA‐binding cylinders suppress SARS‐CoV‐2 replication, highlighting their potential as novel anti‐viral agents.

29 April 2021 in Angewandte Chemie
Verified
Journal Article
Open access
PDF file
LMLazaros Melidis
Lazaros Melidis
HHHarriet James Hill
Harriet James Hill
NCNicholas J. Coltman
Nicholas J. Coltman
SDScott P. Davies
Scott P. Davies
KWKinga Winczura
Kinga Winczura
MHMichael J. Hannon
Michael J. Hannon
The untranslated regions (UTRs) of viral genomes contain a variety of conserved yet dynamic structures crucial for viral replication, providing drug targets for the development of broad spectrum anti‐virals. We combine in vitro RNA analysis with molecular dynamics simulations to build the first 3D models of the structure and dynamics of key regions of the 5′ UTR of the SARS‐CoV‐2 genome. Furthermore, we determine the binding of metallo‐supramolecular helicates (cylinders) to this RNA structure. These nano‐size agents are uniquely able to thread through RNA junctions and we identify their binding to a 3‐base bulge and the central cross 4‐way junction located in stem loop 5. Finally, we show these RNA‐binding cylinders suppress SARS‐CoV‐2 replication, highlighting their potential as novel anti‐viral agents.

20 June 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
KWKinga Winczura
Kinga Winczura
HCHurmuz Ceylan
Hurmuz Ceylan
MSMonika Sledziowska
Monika Sledziowska
MJMatt Jones
Matt Jones
HFHolly Fagarasan
Holly Fagarasan
PGPawel Grzechnik
Pawel Grzechnik
The regulation of transcription is an essential process that allows the cell to respond to various internal and external signals. RNA Polymerase II (Pol II) activity is controlled by a number of factors which bind to the C-terminal domain (CTD) of its largest subunit, RPB1, and stimulate or suppress RNA synthesis. Here, we demonstrate that CTD-interacting proteins, RPRD2, RPRD1B and RPRD1A act as negative regulators of transcription and their levels inversely correlate with the accumulation of nascent and newly transcribed RNA in human cells. We show that the RPRD proteins form mutually exclusive complexes with Pol II to coordinate their roles in transcriptional control. Our data indicate that RPRD2 exerts the most substantial impact on transcription and has the potential to alter key biological processes including the cellular stress response and cell growth.

7 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
KWKinga Winczura
Kinga Winczura
LJLars Joenson
Lars Joenson
EKErich Koller
Erich Koller
PGPawel Grzechnik
Pawel Grzechnik
ŁKŁukasz Jan Kiełpiński
Łukasz Jan Kiełpiński
Antisense oligonucleotides (ASOs) are short, synthetic nucleic acids that bind to complementary RNA sequences and alter gene expression, making them versatile therapeutic agents. Here, we identify transcription termination windows of protein-coding genes as previously unrecognized targets for ASOs. We show that ASOs can act on nascent RNA synthesised downstream of the annotated genes, leading to a pronounced decrease in the corresponding mRNA levels. These downstream-of-gene ASOs (DG-ASOs) induce RNase H1-dependent cleavage, impairing mRNA 3’ end processing, directing the unprocessed mRNAs for exosome-dependent degradation and creating early entry points in the nascent RNA for the XRN2 exonuclease termination factor. Altogether, we show that termination windows are genuine ASO targets which can be exploited to suppress gene expression. Importantly, we also reveal an underappreciated source of off-target effects which may arise from ASOs binding downstream of genes. Our findings indicate the necessity to expand ASO design and off-target assessment guidelines to include termination window sequences, thereby improving therapeutic efficacy and safety.

9 October 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
KWKinga Winczura
Kinga Winczura
LJLars Joenson
Lars Joenson
EKErich Koller
Erich Koller
PGPawel Grzechnik
Pawel Grzechnik
ŁKŁukasz Jan Kiełpiński
Łukasz Jan Kiełpiński
Antisense oligonucleotides (ASOs) are short, synthetic nucleic acids that bind to complementary RNA sequences and alter gene expression, making them versatile therapeutic agents. Here, we identify transcription termination windows of protein-coding genes as previously unrecognised targets for ASOs. We show that ASOs can act on nascent RNA synthesised downstream of the annotated genes, leading to a pronounced decrease in the corresponding mRNA levels. These downstream of gene ASOs (DG-ASOs) induce RNase H1-dependent cleavage, impairing mRNA 3’ end processing, directing the unprocessed mRNAs for exosome-dependent degradation and creating early entry points in the nascent RNA for the XRN2 exonuclease termination factor. Altogether, we show that termination windows are genuine ASO targets which can be exploited to suppress gene expression. Importantly, we also reveal an underappreciated source of off-target effects which may arise from ASOs binding downstream of genes. Our findings indicate the necessity to expand ASO design and off-target assessment guidelines to include termination window sequences, thereby improving therapeutic efficacy and safety.